EULAR 2016 - RheumReports

Past Coverage of EULAR 2016Past Coverage of EULAR 2016 Return To RheumReports Home

JUNE 11

Featured
Musings from EULAR 2016: What Will (or Might) and What Will Not Change my Practice
4:43 PM ET — via Dr. Janet Pope
Featured
AS Wrap Up
1:25 PM ET — via Dr. Shelly Dunne
Featured
A Plethora of SEBs/Biosimilars to Choose From!
1:24 PM ET — via Dr. Janet Pope
Getting Better at the Attribution of Neuropsychiatric Events in SLE
12:07 PM ET — via Dr. Zahi Touma
Royal Sighting!
12:06 PM ET — via Dr. Shelly Dunne
I CAN'T SLEEP!!
12:03 PM ET — via Dr. Zahi Touma
Overview of Large Vessel Vasculitis in the 21st Century
12:02 PM ET — via Dr. Shahin Jamal
New Data on Dermatomyositis and Pregnancy
12:00 PM ET — via Dr. Shahin Jamal
Featured
TNF Inhibitors in Men Wanting to Conceive
11:58 AM ET — via Dr. Shahin Jamal
Predictors of Switching Biologics in PsA Patients
11:57 AM ET — via Dr. Vinod Chandran
Monotherapy in RA? The Jury is Still Out
7:00 AM ET — via Dr. Cathy Flanagan
Work as a Risk Factor for RA
6:00 AM ET — via Dr. Cathy Flanagan
Dose of Glucocorticoids in Lupus Nephritis at YEAR 1 Predicts Accrual of Damage
6:00 AM ET — via Dr. Zahi Touma
Featured
Mortality with Giant Cell Arteritis
6:00 AM ET — via Dr. Shahin Jamal

JUNE 10

RheumReports.com @Rheumreports
Pre-Clinical Use of Rituximab Forestalls Rheumatoid Onset | RheumNow - Rheumatology News & Information https://t.co/dMeKRA9JnW
9:20 PM ET
RheumReports.com @Rheumreports
GiACTA Study Shows Benefit of Adding Tocilizumab to Steroid Taper in Giant Cell Arteritis | RheumNow - https://t.co/EdFPRepqfe
9:20 PM ET
PROMIS in Lupus
8:10 PM ET — via Dr. Zahi Touma
New Data for Ixekizumab in Psoriatic Arthritis
8:10 PM ET — via Dr. Vinod Chandran
Secukinumab vs Adalimumab in AS: Controversial Trial Design
8:09 PM ET — via Dr. Shelly Dunne
Featured
Novel Biologics that Inhibit the Th17 Pathway in Psoriatic Disease
8:08 PM ET — via Dr. Vinod Chandran

Current Event

Loading